Consistent with an in vitro study, our immunofluorescence analysis on the tumour sections of EGCG and PDE3 inhibitor-injected mice demonstrated that the combination regimen also suppressed both FOXO3 and CD44 expression (Fig. 4d). Here, FOXO3 is linked to neoplasm.